CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 234 enrolled
Drug / intervention
Methodological pens +2 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01831635
NCT01831635N/ACompleted

Myeloproliferative Neoplasms: an In-depth Case-control Study

Queen's University, Belfast·observational·Posted Apr 15, 2013·Updated Jan 8, 2024

In Brief

An observational study evaluating Methodological pens, Methodological compensation, and 1 other intervention for Polycythemia Vera and 2 related conditions. Completed, enrolled 234 participants across 3 sites.

Detailed Summary

There is a paucity of data on the aetiology of myeloproliferative neoplasms (MPNs). The investigators conducted a systematic review of the literature which identified several cohort and case-control studies that have investigated a wide range of potential medical, environmental and occupational risk factors. However, these studies have been limited by a wide variation in case definition and small sample sizes limiting the potential to detect modest risk differences between cases and controls. The research group propose an exploratory case-control study of 100 patients with classic MPNs and 200 controls to determine the optimal methods for roll out of this study to a multi-centred UK-based case-control study that will investigate the aetiology of MPN subtypes. The objectives of the study are to evaluate recruitment procedures, response rates and the development of a telephone administered questionnaire. The findings of this exploratory study will form the basis of a protocol for a large United Kingdom (UK)-wide case-control study of MPNs.

Study Details

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedApr 15, 2013
Enrollment StartApr 1, 2013
Primary CompletionJul 1, 2014
Study CompletionJun 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 13.2 years ago

Interventions

Methodological pensother

Randomisation of branded pen, non-branded pen and no pen

Methodological compensationother

Randomisation of a £10 monetary reimbursement for expenses on completion of the study

Methodological trolley tokensother

Trolley tokens to be randomly assigned to half of cases and General Practice controls.